Literature DB >> 22488157

Transient recombinant protein expression in a human amniocyte cell line: the CAP-T® cell system.

Simon Fischer1, Nadine Charara, Andrea Gerber, Jens Wölfel, Gudrun Schiedner, Bernd Voedisch, Sabine Geisse.   

Abstract

The impact of transient gene expression approaches (TGE) on the rapid production of recombinant proteins is undisputed, despite that all efforts are currently relying on two host cell families only, namely HEK293 derivatives and CHO cell line(s). Yet, the increasing complexity of biological targets calls for more than two host cell types to meet the challenges of difficult-to-express proteins. For this reason, we evaluated the more recently established novel CAP-T® cell line derived from human amniocytes for its performance and potential in transient gene expression. Upon careful analyses and adaptation of all process parameters we show here that indeed the CAP-T® cells are extremely amenable to transient gene expression and recombinant protein production. Additionally, they possess inherent capabilities to express and secrete complex and difficult target molecules, thus adding an attractive alternative to the repertoire of existing host cell lines used in transient production processes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488157     DOI: 10.1002/bit.24514

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

Review 1.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

Review 2.  Better and faster: improvements and optimization for mammalian recombinant protein production.

Authors:  Steven C Almo; James D Love
Journal:  Curr Opin Struct Biol       Date:  2014-04-12       Impact factor: 6.809

3.  Human CAP cells represent a novel source for functional, miRNA-loaded exosome production.

Authors:  Nikolas Zeh; Helga Schneider; Sven Mathias; Nadja Raab; Michael Kleemann; Sabine Schmidt-Hertel; Benjamin Weis; Silke Wissing; Nikola Strempel; René Handrick; Kerstin Otte
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

4.  Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells.

Authors:  David L Hacker; Divor Kiseljak; Yashas Rajendra; Sarah Thurnheer; Lucia Baldi; Florian M Wurm
Journal:  Protein Expr Purif       Date:  2013-09-08       Impact factor: 1.650

5.  Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine.

Authors:  Lea Krutzke; Reinhild Rösler; Ellen Allmendinger; Tatjana Engler; Sebastian Wiese; Stefan Kochanek
Journal:  Elife       Date:  2022-07-04       Impact factor: 8.713

6.  Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.

Authors:  Ruben O Donis; C Todd Davis; Angie Foust; M Jaber Hossain; Adam Johnson; Alexander Klimov; Rosette Loughlin; Xiyan Xu; Theodore Tsai; Simone Blayer; Heidi Trusheim; Tony Colegate; John Fox; Beverly Taylor; Althaf Hussain; Ian Barr; Chantal Baas; Jaap Louwerens; Ed Geuns; Min-Shi Lee; Odewijk Venhuizen; Elisabeth Neumeier; Thedi Ziegler
Journal:  Vaccine       Date:  2014-06-24       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.